Reference
Reference
| Article | Papers publication | Year |
|---|---|---|
| Fecal Microbiota Differences According to the Risk of Advanced Colorectal Neoplasms | J Clin Gastroenterol. | 2019 |
| MCM7 polymorphisms associated with the AML relapse and overall survival | Ann Hematol | 2017 |
| Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population | Genet Test Mol Biomarkers | 2016 |
| SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia | Cancer Chemother Pharmacol | 2016 |
| A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data | Blood Res | 2016 |
| Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML | J Hum Genet | 2015 |
| Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome Sequencing | Int J Genomics | 2015 |
| Establishment of cell lines from both myeloma bone marrow and plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a single patient | Biomed Res Int | 2014 |
| NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia | Pharmacogenet Genomics | 2014 |
| Establishment and characterization of bortezomib-resistant U266 cell line: constitutive activation of NF-κB-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis | BMB Rep | 2014 |
| TNF α mediated IL-6 secretion is regulated by JAK/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells | Biomed Res Int | 2013 |
| Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients | Eur J Cancer | 2013 |
| A role for benzo[a]pyrene and Slug in invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis: a potential molecular link between smoking and radiographic progression | Joint Bone Spine | 2013 |
| Copy number variations in normal karyotype acute myeloid leukaemia and their association with treatment response | Basic Clin Pharmacol Toxicol | 2012 |
R&D
| No. | Program Name (Agency) | Project Name |
|---|---|---|
| 1 | R & D enterprise growth support business | Real-time Cell Character Analysis Equipment |
| (R & D Special Zone Promotion Foundation) | ||
| 2 | Technology Transfer Project – Investment-linked R & BD | Development of real-time blood cancer cell characterization platform for cancer progress prediction integrated system (CRMSI) |
| (R & D Special Zone Promotion Foundation) | ||
| 3 | Funding for commercialization of TIPS | micro-residual cancer cells and separated incubator (MRDsys) product and service, and development platform of MRDsys for the prediction of cancer recurrence |
| (Business Development Agency) | ||
| 4 | TIPS Overseas Marketing Support Project | Development of real-time cell tracking system for biological characterization of cells |
| (Business Development Agency) | ||
| 5 | TIP program private investment-led technology start-up support project | Development of a Deep Learning-based Transition Prediction Algorithm Using Blood Cancer Cellular Dielectric Information |
| (Small and Medium Business Technical Information Agency) | ||
| 6 | Individual Basic Research | Identification of target genes related to characterization of micro-residual cancer cells and anti-cancer drug resistance |
| (Korea Research Foundation) | ||
| 7 | Development of original technology of SW computing industry | Development of HPC system for high-speed deep processing |
| (Information and Communication Technology Promotion Center) | ||
| 8 | Start-up tailored commercialization support project | Development of cfDNA genome analysis system for cancer progress prediction |
| (Business Development Agency) | ||
| 9 | First step technology development business | Separation of micro-residual cancer cells and development of culture technique |
| (Small and Medium Business Technical Information Agency) | ||
| 10 | Primary cell supply system establishment project | primary cell supply system building demonstration project |
| (Disease Control Headquarters) |
Patents
| No. | Patent / Program Name | Country | Application / registration date | Application / Registration Number | Remarks |
|---|---|---|---|---|---|
| 1 | Prediction of Glaucoma | Korea | 12-29-18 | 10-2018-0173202 | Patent application |
| 2 | Dementia Prediction System Based on Deep Learning Flatform | Korea | 12-01-18 | 10-2018-0153200 | Patent application |
| 3 | Micro-residual cancer cell culture incubator | Korea | 10-31-18 | 10-2018-0132478 | Patent application |
| 4 | Cancer recurrence and metastasis monitoring method and system | Korea | 11-09-16 | 10-2016-0149000 | Patent application |
| 5 | Genome information analysis | Korea | 04-25-16 | 10-2016-0049871 | Patent application |
| 6 | Lipolysis device | Korea | 01-12-12 | 10-1332791 | Patent registration |
| 7 | Terminal structure for reducing the in vivo organ and tissue damage upon contact | Korea | 09-28-11 | 10-1070275 | Patent registration |
| 8 | Living cell activity assay method | Korea | 07-14-11 | 10-1050790 | Patent registration |
Awards
| No. | Awards name | Organizer | year |
|---|---|---|---|
| 1 | No. 1 of the First Medical Big Data Analysis Contest | Seoul Asan Hospital & Korea Microsoft | 2017 |
| 2 | Digital Innovation Award (Separation and culture technique development of fine residual cancer cells) |
Ministry of Science and Technology, Ministry of Information and Communication,_x000D_ Korea Times |
2017 |
| 3 | Small and Medium Enterprise Technology Award (Biotechnology) | Economic focus | 2017 |
